Kasper Johansen Mygind

Kasper Johansen Mygind is an Assistant Professor in the Erler Group at the University of Copenhagen's Faculty of Health and Medical Sciences (SUND) and the Biotech Research and Innovation Centre (BRIC), based at Ole Maaløes Vej 5 in Copenhagen, Denmark.

His research focuses on:

• Cancer metastasis and tumor microenvironment dynamics
• Integrin signaling and cell adhesion mechanisms
• ADAM metalloproteinase regulation of extracellular matrix
• Protein O-mannosylation in genetic disorders

Analysis of his 2015-2024 publications reveals consistent investigation into how ADAM proteases (ADAM9, ADAM12, ADAM17) modulate $$\beta_1$$ integrin function, extracellular matrix remodeling, and cancer cell migration, with recent expansion into glycosylation enzymes like TMEM260 for rare syndromes.

No scientific awards were mentioned in the source material.

No information regarding student supervision or research grants was provided.

Dr. Mygind conducts research within the Erler Group at BRIC, a specialized unit focused on molecular mechanisms of cancer metastasis and therapeutic development.